Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.00
+0.30 (1.69%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fulgent Genetics stock has a target of $15, which predicts a -16.67% decrease from the current stock price of 18.
Price Target: $15 (-16.67%)
Analyst Consensus: Hold
* Price targets were last updated on May 5, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Fulgent Genetics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $30 → $15 | Hold | Reiterates | $30 → $15 | -16.67% | May 5, 2026 |
| UBS | UBS | Buy Maintains $35 → $22 | Buy | Maintains | $35 → $22 | +22.22% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
352.20M
from 322.67M
Increased by 9.15%
Revenue Next Year
401.70M
from 352.20M
Increased by 14.05%
EPS This Year
-1.55
from 0.42
EPS Next Year
-1.15
from -1.55
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 352.2M | ||
| Avg | 352.2M | ||
| Low | 352.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.2% | ||
| Avg | 9.2% | ||
| Low | 9.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -1.55 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |